- Pestka, S., Langer, J.A., Zoon, K.C. and Samuel, C.E. (1987) "Interferons and their actions", Annual Review of Biochemistry 56, 727-777.
- Gutterman, J.U. (1994) "Cytokine therapeutics: lessons from interferon a", Proceedings of the national Academy of Sciences USA 91, 1198-1205.
- Platanias, L.C. (1995) "Interferons. Laboratory to clinic investigations", Current Opinion in Oncology 7, 560-565.
- Stark, G.R., Kerr, I.M., Williams, B. R.G., Silverman, R.H. and Screiber, R.D. (1998) "How cells respond to interferons", Annual Review of Biochemistry 67, 227-264.
- The Italian Cooperative Study group on Chronic myeloid leukemia(1991) "Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia", New England Journal of Medicine 27, 53-57.
- Groften, J., Stephenson, J.R., Heisterkamp, N., de Klein, A., Bartram, C.R and Grosveld, G. (1984) "Philadelphia chromosomal breakpoints are clustered within a limited region. bcr, on chromosome 22", Cell 36, 93-99.
- Daley, G.Q., Van Etten, R.A. and Baltimore, D (1990) "Blast crisis in a murine model of chronic myclogenous leukemia", Science 247, 824-830.
- Lugo, T.C., Pendergast, A.M., Muller, A.J. and Witte, O.N. (1990) "Tyrosine kinase activity and transformation potency of bcr-abl oncogene products", Science 247, 1079-1082.
- Kelliher, M.A., Mc Laughlin, J., Witte, O.N. and Rosenberg, A. (1990) "Induction of chronic myelogenous leykemia like syndrome in mice with v-abl and BCR-ABL", Proceedings of the National Academy of Sciences USA 87, 6649-6653.
- Sawyers, C.L. (1999) "Chronic myeloid leukemia", New England Journal of Medicine 340, 1330-1340.
- Kantarjian, H.M., O'Brien, S., Smith, T.L., Rios, M.B., Cortes, J., Beran, M., Koller, C., Giles, F.J., Andreeff, M., Kornblau, S., Giralt, S., Keating, M.J. and Talpaz, M. (1999) "Treatment of Philadelphia chromosome-positive early chronic phase chronic myelogenous leukemia with daily doses of interferon alpha and low-dose cytarabine", Journal of Clinical Oncology 17, 284-292.
- Bhatia, R., Wayner, E.A., McGlave, P.B. and Verfaillie, C.M. (1994) "Interferon-alpha restores normal adhesion of chronic myelogenous leukemia hematopoietic progenitors to bone marrow stroma by correcting impaired beta 1 integrin receptor function", Journal of Clinical Investigation 94, 384-391.
- Bhatia, R., McGlave, P.B. and Verfaillie, C.M. (1995) "Treatment of marrow stroma with interferon-alpha restores normal beta 1 integrin-dependent adhesion of chronic myelogenous leukemia hematopoietic progenitors. Role of MIP-1 alpha", Journal of Clinical Investigation 96, 931-939.
- Bhatia, R., McCarthy, J.B. and Verfaillie, C.M. (1996) "Interferon-alpha restores normal beta 1 integrin-mediated inhibition of hematopoiclic progenitor proliferation by the marrow microenvironment in chronic myelogenous leukemia", Blood 87, 3883-3891.
- Bhatia, R. and Verfaillie, C.M. (1998) "The effect of interferon-alpha on beta-1 integrin mediated adhesion and growth regulation in chronic myelogenous leukemia", Leukemia and Lymphoma 2, 41-254.
- Pane, F., Mostarda, L. Selleri, C., Salzano, R., Raiola, A.M., Luciano, L., Saglio, G., Rotoli, B. and Salvatore, F. (1999) "BCR/ABL mRNA and the P210(BCR/ABL) protein arc down-modulated by interferon-alpha in chronic myeloid leukemia patients", Blood 94, 2200-2207.
- Colamonici, O.R., Pfeffer, L., D'Alessandro, F., Platanias, L.C., Rosolen, A., Nordan, R., Cruciani, R.A. and Diaz, M.O. (1992) "Multichain structure of the Interferon alpha-2 receptor on hematopoietic cells", Journal of Immunology 148, 2126-2132.
- Platanias, L.C., Pfeffer, L.M., Cruciani, R. and Colamonici, O.R. (1993) "Characterization of the a-subunit of the IFNa receptor: Evidence of N- and O-linked glycosylation and association with other surface proteins", Journal of Immunology 150, 7382-3388.
- Platanias, L.C. Pfeffer, L.M., Barton, K., Vardiman, J.W., Golomb, H.M. and Colamonici, O.R. (1992) "Expression of the IFNa receptor in bairy cell leukemia cells", British Journal of Haematology 82, 541-546.
- Uzé, G., Lutfalla, G. and Gresser, I. (1990) "Genetic transfer of a functional human Interferon a receptor into mouse cells: cloning and expression of its cDNA", Cell 60, 225-232.
- Novick, D., Cohen, B. and Rubinstein, M. (1994) "The human interferon a/ß receptor characterization and molecular cloning", Cell 77, 391-400.
- Lutfalla, G., Holland, S.J., Ginato, E., Monneron, D., Reboul, J., Rogers, N.C., Smith, J.M., Stark, G.R., Gardiner, K., Mogensen, K.E., Kerr, l.M. and Uzé, G. (1995) "Mutant U5A cells are complemented by an interferon-alpha beta receptor subunit generated by alternative processing of a new member of a cytokine receptor gene cluster", EMBO Journal 14, 5100-5107.
- Domanski, P., Witte, M., Kellum, M., Rubinstein, M., Hackett, R., Pitha, P. and Colamonici, O.R. (1995) "Cloning and expression of a long form of the beta subunit of the interferon alpha/beta receptor that is required for signaling", Journal of Biological Chemistry 270, 21606-21611.
- Darnell, Jr., J.E., Kerr, I.M. and Stark, G.R. (1994) "Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular proteins", Science 264, 1415-1420.
- Darnell, Jr., J.E. (1997) "Stats and gene regulation", Science 277, 1630-1635.
- Darnell, Jr., J.E. (1998) "Studies of IFN-induced transcriptional activation uncover the Jak-Stat pathway", Journal of Interferon and Cytokine Research 18, 549-554.
- Platanias, L.C. and Fish, E.N. (1999) "Signaling pathways activated by interferons", Experimental Hematology 27, 583-1592.
- Meinke, A., Barahmand-Pour, F., Wohrl, S., Stoiber, D. and Decker, T. (1996) "Activation of different Stat5 isoforms contributes to cell-type-restricted signaling in response to interferons", Molecular and Cellular Biology 16, 6937-6944.
- Sattker, M. and Salgia, R. (1998) "Role of the adapter protein CRKL in signal transduction of normal hematopoietic and BCR/ABL-transformed cells", Leukemia 12, 637-644.
- Ahmad, S., Alsayed, Y., Druker, B.J. and Platanias, L.C. (1997) "The Type 1 interferon receptor mediates tyrosine phosphorylation of the CrkL adaptor protein", Journal of Biological Chemistry 272, 29991-29994.
- Alsayed, Y., Uddin, S., Ahmad, S., Majchrzak, B., Druker, B.J. Fish, E.N. and Platanias, L.C. (2000) "Interferon ? activates the C3G-Rap1 signaling pathway", Journal of Immunology, 164, 1800-1806.
- Kitayama, H., Sugimoto, Y., Matsuzaki, T., Ikawa, Y. and Noda, M. (1989) "A ras-related gene with transformation suppressor activity", Cell 56, 77-84.
- Kitayama, H., Matsuzaki, T., Ikawa, Y and Noda, M. (1990) "Genetic analysis of the Kirsten-ras-revertant 1 gene:potentiation of its tumor suppressor activity by specific point mutations", Proceedings of the National Academy of Sciences, USA 87, 4284-4288.
- Cook, S., Rubinfeld, B., Albert, I. and McCormick, F. (1993) "RapV12 antagonizes Ras-dependent activation of ERK1 and ERK2 by LPA and EGF in Rat-1 fibroblasts", EMBO Journal 12, 3475-3485.
- Fish, E.N., Uddin, S., Korkmaz, M., Majchrzak, B., Druker, B.J. and Platanias, L.C. (1999) "Activation of a CrkL-Stat5 signaling complex by Type 1 interferons", Journal of Biological Chemistry 274, 571-573.
- Oda, A., Wakao, H., Fujihara, M., Ozaki, K., Komatsu, N., Tanaka, S., Ikeda, H., Miyajima, A. and Ikebuchi, K. (2000) "Thrombopoietin and interleukin-2 induce association of CRK with STAT5", Biochemical Biophysical Research Communications 278, 299-305.
- Schulze, H., Ballmaier, M., Welte, K. and Germeshausen, M. (2000) ''Thrombopoietin induces the generation of distinct Stat1, Stat3, Stat5a and Stat5b homo- and heterodimeric complexes with different kinetics in human platelets", Experimental Hematology 28, 294-304.
- Oda, A., Sawada, K., Druker, B.J., Ozaki, K., Takano, H., Koizumi, K. Fukada, Y., Handa, M., Koike, T. and Ikeda, Y. (1998) "Erythropoietin induces tyrosine phosphorylation of Jak2, STAT5 A, and STAT5B in primary cultured human erythroid precursors", Blood 92, 443-451.
- Du, J., Alsayed, Y. Xin, F., Ackerman, S.J. and Platanias, L.C. (2000) "Engagement of the CrkL adapter in interleukin-5 signaling in cosinophils", Journal of Biological Chemistry 275, 33167-33175.
- Platanias, L.C. Uddin, S., Bruno, E., Korkmaz., M., Ahmad, S., Alsayed, Y. Van Den Berg, D., Druker, B.J., Wickrema, A. and Hoffman, R (1999) "CrkL and CrkII participate in the generation of the growth inhibitory effects of interferons on primary hematopoietic progenitors", Experimental Hematology, 27, 1315-1321.
- Sattler, M., Salgia, R., Okuda, K., Uemura, N., Durstin, M.A., Pisick, E., Xu, G., Li, J.-L., Prasad, K. and Griffin, J.D. (1996) "The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3/ kinase pathway", Oncogene 12, 839-846.
- Heaney, C. Kolibaba, K., Bhat, A., Oda, T. Ohno, S., Fanning, S. and Druker, B.J. (1997) "Direct binding of CrkL to BCR-ABL is not required for BCR-ABL transformation", Blood 89, 297-306.
- Oda, T., Heaney, C., Hagopian, J.R., Okuda, K., Griffin, J.D. and Druker, B.J. (1994) "Crk1 is the major tyrosine-phosphorylated protein in neutrophils from pateints with chronic myelo- genous leukemia", Journal of Biological Chemistry 269, 22925-22928.
- Nichols, G.L., Raines, M.A., Carlos Vera, J., Lacomis, L., Tempst, P. and Golde, D.W. (1994) "Identification of CRKL as the constitutively phosphorylated 39-kD tyrosine phosphoprotein in chronic myelogenous leukemia cells", Blood 84, 2912-2918.
- Ten Hoeve, J., Arlinghaus, R.B., Qiang Guo, J., Heisterkamp, N. and Groffen, J. (1994) "Tyrosine phosphorylation of CRKL in Philadelphia+ leukemia", Blood 84, 1731-1736.
- Grumbach, I.M., Mayer, I.A., Uddin, S., Lekmine, F., Majchrzak, B., Yamauchi, H., Fujita, S., Druker, B.J., Fish, K.N. and Platanias, L.C (2001) "Engagement of the CrkL adapter in interferon a signaling in BCR-ABL expressing cells", British Journal of Haematology 112, 327-336.
- Stadler, M., Chelbi-Alix, M.K., Koken, M.H.M., Nenturini, L., Lee, C., Saib, A., Quignon, F., Pelicano, L., Guillemin, M.-C., Schindler, C. and de The, H. (1995) "Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element", Oncogene 11, 2565-2573.
- Rhodes, J., York, R.D., Tara, D., Tajinda, K. and Druker, B.J. (1999) "CrkL functions as a nuclear adaptor and transcriptional activator in Bcr-Abl-expressing cells", Experimental Hematology 28, 305-310.
- Kyriakis, J.M. and Avruch, J. (1996) "Sounding the alarm: protein kinase cascades activated by stress and inflammation", Journal of Biological Chemistry 271, 24313-24316.
- Schaeffer, H.J. and Weber, M.J. "Mitogen-activated protein kinases: specific messages from ubiquitous messengers", (1999) Molecular and Cellular Biology 19, 2435-2444.
- Lee, J.C., Laydon, J.T., McDonnell, P.C., Gallagher, T.F., Kumar, S., Green, D., McNulty, D., Blumenthal, M.J., Heys, J.R., Landvatter, S.W., Strickler, J.F., McLaughlin, M.M., Siemens, I.R., Fisher, S.M., Livi, G.P., White, J.R., Adams, J.L. and Young, P.R. (1994) "A protein kinase involved in the regulation of inflammatory cytokine biosynthesis", Nature 372, 739-746.
- Han, J., Lee, J.D., Bibbs, L. and Ulevirch, R.J. (1994) "A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells", Science 265, 808-811.
- Rouse, J., Cohen, P., Trigon, S., Moronge, M., Alonsos-Llamazares, A., Zamanillo, D., Hunt, T. and Nebreda, A.R. (1994) "A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of small heat shock proteins", Cell 78, 1027-1037.
- Freshney, K.W., Rawlinson, L., Guedson, F. Jones, H., Cowley, S., Hsuan, J. and Saklatvala, J. (1994) "Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of the Hsp27", Cell 78, 1039-1049.
- Goebert, M., Cuenda, A., Craxton, M., Jakes, R. and Cohen, P. (1997) "Activation of the novel stress-activated protein kinase SAPK4 by cytokines and cellular stresses is mediated by SKK3 (MKK6): comparison of its substrate specificity with that of other SAP kinases", EMBO Journal 16, 3563-3571.
- Brewater, J.L., De, V.T., Dwyer, N.D., Winter, E. and Gustin, M.C. (1993) "An osmosensing signal transduction pathway in yeast", Science 259, 1760-1763.
- Raingeaud, J., Whitmarsh, A.J., Barrett, T., Derijard, B. and Davis, R.J. (1999) "MKK3- and MKK6- regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway", Molecular and Cellular Biology 16, 1247-1155.
- Han, J., Jiang, Y. Li, Z., Kravchenko, V.V. and Ulevitch, R.J. (1997) "Activation of the transcription factor MER2C by the MAP kinase p38 in inflammation", Nature 386, 296-299.
- Baldassare, J.J., Bi, Y. and Bellone, C.J. (1999) "The role of p38 mitogen-activated protein kinase in IL 1b transcription", Journal of Immunology 162, 5367-5373.
- Thureauf, D.J., Arnold, N.D., Zechner, D., Handford, D.S., DeMartin, K.M., McDonough, P.M., Prywes, R. and Glembotski, C.C. (1998) "p38 mitogen-activated protein kinase mediates the transcriptional induction of the atrial matriuretic factor gene through a serum response element", Journal of Biological Chemistry 273, 20636-20643.
- Vanden Berghe, W., Plaisance, S., Boone, E., De Bosscher, K., Schmitz, M.L., Fiers, W. and Haegeman, G. (1998) "p38 and extracellular signal-regulated kinase milogen-activated protein kinase pathways are required for nuclear factor-kB p65 transactivation mediated by tumor necrosis factor", Journal of Biological Chemistry 273, 3285-3290.
- Miyazawa, K., Mori, A., Miyata, H., Akahane, M., Ajisawa, Y. and Okudaira, H. (1998) "Regulation of interleukin 1ß-induced interleukin-6 gene expression in human fibroblast-like synoviocytes by p38 mitogen-activated protein kinase", Journal of Biological Chemistry 273, 24832-24838.
- Zhao, M., New, L., Kravchenko, V.V., Kato, Y. Gram, H., Di Padova, F., Olson, E.N., Ulevitch, R.J. and Han, J. (1999) "Regulation of the MEF2 family of transcription factors by p38", Molecular and Cellular Biology, 19, 21-30.
- Schafer, C., Ross, S.E., Bragado, M.J., Groblewski, G.E., Ernst, S.A. and Williams, J.A. (1998) "A role for the p38 mitogen-activated protein kinase/Hsp27 pathway in cholecystokinin-induced changes in the actin cytoskeleton in rat pancreatic acini", Journal of Biological Chemistry 273, 24173-24180.
- Xia, Z., Dickens, M., Raingeaud, J., Davis, R.J. and Greenberg, M.E. (1995) "Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis", Scienre 270, 1326-1331.
- Ichijo, H., Nishida, E., Irie, K., ten Dyke, P., Saitoh, M., Moriguchi, T., Takagi, M., Matsumato, K., Miyazono, K. and Gotoh, Y. (1997) "Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways", Science 275, 90-94.
- Krumer, J.L., Rao, P.K. and Heidenreich, K.A. (1997) "Apoptosis induced by withdrawal of trophic factors is mediated by p38 mitogen-activated protein kinase", Journal of Biological Chemistry 272, 20490-20494.
- Nagata, Y. Takahashi, N. Davis, R.J. and Tokodoro, K. (1998) "Activation of p38 MAP kinase and JNK but not ERK is required for erythropoietin-induced crythroid differentiation", Blood 92, 1859-1869.
- Alsayed, Y., Uddin, S., Mahmud, N., Lekmine, F., Kalvakolanu, D.V., Minnucci, S. Bokoch, G. and Platanias, L.C. (2001) "Activation of Rac1 and the p38 Map kinase pathway in response to all-trans-retinoic acid", Journal of Biological Chemistry 272, 4012-4019.
- Robinson, M.J. and Cobb, M.H. (1997) "Mitogen-activated protein kinase pathways", Current Opinion in Cell Biology 9, 180-186.
- Derijard, B., Raingeaud, J., Barren, T., Wu, I.-H., Han, J., Ulevitch, R.J. and Davis, R.J. (1995) "Independent human MAP kinase signal transduction pathways defined by MEK and MKK isoforms", Science 267, 682-685.
- Lin, A., Minden, A., Martinetto, H., Claret, F.X., Lange-Carter, C., Mercurio, F., Johnson, G.L. and Karin, M. (1995) "Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2", Science 268, 286-290.
- Sanchez, I.R., Hughes, R.T., Mayer, B.J., Yee, K., Woodgett, J.R., Avruch, J., Kyriakis, J.M. and Zon, L.I. (1994) "Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun", Nature 372, 794-798.
- Han, J., Lee, J.-D., Jiang. Y., Zhuangjie, L., Feng, L. and Ulevitch, R.J. (1996) "Characterization the structure and function of a novel MAP kinase kinase (MKK6)", Molecular and Cellular Biology 271, 2886-2891.
- Moriguchi, T., Kuriyanagi, N., Yamaguchi, K., Gotoh, Y., Irie, K., Kano, T., Shirakabe, K., Muro, Y., Shibuya, H., Matsumoto, K., Nishida, E. and Hagiwara, M. (1996) "A novel kinase cascade mediated by mitogen-activated protein kinase 6 and MKK3", Journal of Biological Chemistry 271, 13765-13769.
- Stein, B., Brady, H., Yang, M.X., Young, D.B. and Barbosa, M.S. (1996) "Cloning and characterization of MEK6, a novel member of the mitogen activated protein kinase kinase cascade", Journal of Biological Chemistry 271, 11427-11433.
- Enslen, H., Raingeaud, J. and Davis, R.J. (1998) "Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6", Journal of Biological Chemistry 273, 1741-1748.
- Shibuya, H., Yamaguchi, K., Shirakabe, K., Tonegawa, A., Gotoh, Y., Ueno, N., Trie, K., Nishida, E. and Matsumoto, K. (1996) "TAB1: an activator of the TAK-1 MAPKKK in TGF-b signal transduction", Science 272, 1179-1182.
- Shirakabe, K., Yamaguchi, K., Shibuya, H., Irie, K., Matsuda, S., Moriguchi, T., Gotoh, Y., Matsumoto, K. and Nishida, E. (1997) "TAK1 mediates the ceramide signaling to stress-activated protein kinase/c-Jun N-terminal kinase", Journal of Biological Chemistry 272, 8141-8144.
- Yamaguchi, K., Shirakabe, K., Shibuya, H., Irie, K., Oishi, I., Ueno, N., Taniguchi, T., Nishida, E. and Matsumoto, K. (1995) "Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction", Science 270, 2008-2011.
- Tibbles, L.A., Ing, Y.L., Kiefer, F., Chan, J., Iscove, N., Woodgett, J.R and Lassam, N.J. (1996) "Mlk-3 activates the SAPK/JNK and p3a/RK pathways via SHK1 and MKK3/6", EMBO Journal 15, 7026-7035.
- Zhang, S., Han, J., Sells, M.A., Chernoff, J., Knaus, U.G., Ulevitch, R.J. and Bokoch, G.M. (1995) "Rho family GTPases regulate p38 mitogen-activated protein kinase through the downstream mediator Pak1", Journal of Biological Chemistry 270, 23934-23936.
- Frost, J.A., Xu, S., Butchison, M.R., Marcus, S. and Cobb, M.H. (1996) "Actions of Rho family small G proteins and p21-activated protein kinases on mitopen-activated protein kinase family members", Molecular and Cellular Biology 16, 3707-3713.
- Uddin, S., Sharma, N., Majchrzak, B., Mayer, I., Lekmine, F., Young, P.R., Bokoch, G.M., Fish, E.N. and Platanias, L.C. (2000) "The Rac1/p38 Map kinase pathway is required for IFNa-dependent transcriptional activation but not serine phosphorylation of Stat-proteins", Journal of Biological Chemistry 275, 27634-27640.
- Alsayed, Y., Uddin, S., Mahmud, N., Kalvakolanu, D., Minnucci, S., Bokoch, G. and Platanias, L.C. (2001) "Activation of Rac1 and the p38 Map kinase pathway in response to all-trans-retinoic acid", Journal of Biological Chemistry 276, 4012-4019.
- Uddin, S., Mazchrzak, B., Woodson, J., Arunkumar, P., Alsayed, Y. Pine, R., Young, P.R., Fish, E.N. and Platanias, L.C. (1999) "Activation of the p38 Map kinase by Type I IFNs", Journal of Biological Chemistry 274, 30127-30131.
- Mayer, I.A., Verma, A., Grumbach, I.M., Uddin, S., Lekmine, F., Ravandi, F., Majchrzak, B., Fujita, S., Fish, E.N. and Platanias, L.C. (2001) "The p38 Map kinase pathway mediates the growth inhibitory effects of IFNsa in BCR-ABL expressing cells", Journal of Biological Chemistry 276, 28570-28577.
- Yanagisawa, K., Yamauchi, H., Kaneko, M., Kohno, H., Hasegawa, H. and Fujita, S. (1998) "Suppression of cell proliferation and the expression of a bcr-abl fusion gene and apoptotic cell death in a new human chronic myclogenous leukemia cell line, KT-1, by interferon-alpha", Blood 91, 641-648.
- Druker, B.J., Sawyers, C.L., Kantarjian, H., Resta, D.J., Reese, S.F., Ford, J.M., Capdeville, R. and Talpaz, M. (2001) "Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome", New England Journal of Medicine 344, 1038-1042.
- Druker, B.J., Talpaz, M., Resta, D.J., Peng, B., Buchdunger, E., Ford, J.M., Lydon, N.B., Kantarjian, H., Capdeville, R., Ohno-Jones, S. and Sawyers, C.L. (2001) "Efficacy and safely of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia", New England Journal of Medicine 344, 1031-1037.
Signaling Via the Interferon-α Receptor in Chronic Myelogenous Leukemia Cells
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.